<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=137417"><dc:title>Ibogaine-mediated ROS/antioxidant elevation in isolated rat uterus is β-adrenergic receptors and K$_{ATP}$ channels mediated</dc:title><dc:creator>Tatalović,	Nikola	(Avtor)
	</dc:creator><dc:creator>Vidonja-Uzelac,	Teodora	(Avtor)
	</dc:creator><dc:creator>Oreščanin-Dušić,	Zorana	(Avtor)
	</dc:creator><dc:creator>Nikolić-Kokić,	Aleksandra	(Avtor)
	</dc:creator><dc:creator>Bresjanac,	Mara	(Avtor)
	</dc:creator><dc:creator>Blagojević,	Duško	(Avtor)
	</dc:creator><dc:subject>ibogaine</dc:subject><dc:subject>K$_{ATP}$ channels</dc:subject><dc:subject>glibenclamide</dc:subject><dc:subject>β-adrenergic receptors</dc:subject><dc:subject>propranolol</dc:subject><dc:subject>antioxidative enzymes</dc:subject><dc:subject>superoxide dismutase</dc:subject><dc:subject>catalase</dc:subject><dc:subject>uterus</dc:subject><dc:subject>contractility</dc:subject><dc:description>Ibogaine effects are mediated by cellular receptors, ATP depletion followed by ROS production and antioxidant enzyme activity elevation in a dose and time dependent manner. Since the role of K$_{ATP}$ channels and β-adrenoceptors in ROS cellular circuit was established here we explored their role in ibogaine pro-antioxidant effectiveness. Single dose of ibogaine (10 mg/L i.e., 28.8 µmol/L) was applied to isolated rat uterus (spontaneous and Ca$^{2+}$-stimulated) and contractility and antioxidant enzymes activity were monitored during 4 h. Ibogaine increased amplitude and frequency of spontaneous active uteri immediately after addition that was prevented by propranolol (β$_1$ and β$_2$ adrenoceptors selective antagonists) and glibenclamide (K$_{ATP}$ sensitive channels inhibitor; only frequency) pre-treatment. In Ca$^{2+}$-stimulated uteri, ibogaine decreased both amplitude and frequency after 4 h. Pre-treatment with propranolol abolished ibogaine induced amplitude lowering, while glibenclamide had no effect. In both types of active uterus, ibogaine induced a decrease in SOD1 and an increase in CAT activity after 2 h. In Ca$^{2+}$-stimulated uterus, there was also a decrease of SOD2 activity after 2 h. After 4 h, SOD1 activity returned to the baseline level, but GSH-Px activity increased. Pre-treatment with both propranolol and glibenclamide abolished observed changes of antioxidant enzymes activity suggesting that ibogaine pro-antioxidative effectiveness is β-adrenergic receptors and K$_{ATP}$ channels mediated.</dc:description><dc:date>2021</dc:date><dc:date>2022-06-16 10:11:40</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>137417</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
